📣 VC round data is live. Check it out!
- Public Comps
- Lucyd
Lucyd Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lucyd and similar public comparables like Wearable Devices, Inventionmed, Predict, CollPlant and more.
Lucyd Overview
About Lucyd
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
Founded
2019
HQ

Employees
11
Website
Financials (LTM)
EV
$444K
Valuation Multiples
Start free trialLucyd Financials
Lucyd reported last 12-month revenue of $5M and negative EBITDA of ($8M).
In the same LTM period, Lucyd generated $1M in gross profit, ($8M) in EBITDA losses, and had net loss of ($8M).
Revenue (LTM)
Lucyd P&L
In the most recent fiscal year, Lucyd reported revenue of $3M and EBITDA of ($8M).
Lucyd is unprofitable as of last fiscal year, with gross margin of 21%, EBITDA margin of (286%), and net margin of (285%).
Financial data powered by Morningstar, Inc.
Lucyd Stock Performance
Lucyd has current market cap of $6M, and enterprise value of $444K.
Market Cap Evolution
Lucyd's stock price is $0.96.
Lucyd share price decreased by 8.1% in the last 30 days, and by 33.4% in the last year.
Lucyd has an EPS (earnings per share) of $-1.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $444K | $6M | -4.9% | -8.1% | -12.3% | -33.4% | $-1.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLucyd Valuation Multiples
Lucyd trades at 0.1x EV/Revenue multiple, and (0.1x) EV/EBITDA.
EV / Revenue (LTM)
Lucyd Financial Valuation Multiples
As of June 4, 2026, Lucyd has market cap of $6M and EV of $444K.
Lucyd has a P/E ratio of (0.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lucyd Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lucyd Margins & Growth Rates
Lucyd grew revenue by 171% but EBITDA decreased by 3% in the last fiscal year.
In the most recent fiscal year, Lucyd reported gross margin of 21%, EBITDA margin of (286%), and net margin of (285%).
Lucyd Margins
Lucyd Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Lucyd Operational KPIs
Lucyd's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.8M for the same period.
Lucyd's Rule of 40 is 68% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lucyd's Rule of X is 323% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Lucyd Competitors
Lucyd competitors include Wearable Devices, Inventionmed, Predict, CollPlant, ScandiDos, Redsense Medical, Spineway, enVVeno Medical, SpectraCure and Vicarious Surgical.
Most Lucyd public comparables operate across Medical Devices, Wearables, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| (18.5x) | - | 1.5x | - | |||
| 7.9x | - | 20.8x | - | |||
| 0.5x | - | 4.3x | - | |||
| 1.8x | - | (0.4x) | - | |||
| 0.7x | - | 17.6x | - | |||
| 2.3x | - | (8.3x) | - | |||
| 0.2x | 0.2x | (3.5x) | (3.3x) | |||
| - | - | 0.8x | - | |||
This data is available for Pro users. Sign up to see all Lucyd competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lucyd
| When was Lucyd founded? | Lucyd was founded in 2019. |
| Where is Lucyd headquartered? | Lucyd is headquartered in United States. |
| How many employees does Lucyd have? | As of today, Lucyd has over 11 employees. |
| Who is the CEO of Lucyd? | Lucyd's CEO is Harrison R. Gross. |
| Is Lucyd publicly listed? | Yes, Lucyd is a public company listed on Nasdaq. |
| What is the stock symbol of Lucyd? | Lucyd trades under LUCY ticker. |
| When did Lucyd go public? | Lucyd went public in 2022. |
| Who are competitors of Lucyd? | Lucyd main competitors include Wearable Devices, Inventionmed, Predict, CollPlant, ScandiDos, Redsense Medical, Spineway, enVVeno Medical, SpectraCure, Vicarious Surgical. |
| What is the current market cap of Lucyd? | Lucyd's current market cap is $6M. |
| What is the current revenue of Lucyd? | Lucyd's last 12 months revenue is $5M. |
| What is the current revenue growth of Lucyd? | Lucyd revenue growth (NTM/LTM) is 194%. |
| What is the current EV/Revenue multiple of Lucyd? | Current revenue multiple of Lucyd is 0.1x. |
| Is Lucyd profitable? | No, Lucyd is not profitable. |
| What is the current EBITDA of Lucyd? | Lucyd has negative EBITDA and is not profitable. |
| What is Lucyd's EBITDA margin? | Lucyd's last 12 months EBITDA margin is (164%). |
| What is the current EV/EBITDA multiple of Lucyd? | Current EBITDA multiple of Lucyd is (0.1x). |
| How many companies Lucyd has acquired to date? | Lucyd hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Lucyd has invested to date? | Lucyd hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Lucyd
Lists including Lucyd
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.